PRKCD and melanoma: Moreover, a significant enhancement of PKCα membrane translocation was observed after PMA treatment in compared to PKCδ in melanoma cells (Figure 1C), which further suggested that melanoma tumor cells selectively enhanced the activity of PKCα and suppressed the activity of PKCδ.